MAT2A inhibitor 5

Compound 39 is a potent, selective, and orally bioavailable MAT2A inhibitor with an IC50 of 11 nM, capable of crossing the blood-brain barrier. It demonstrates robust antitumor efficacy in vivo, making it a valuable chemical probe for oncology research, particularly in studying methionine metabolism and tumor cell proliferation.